Category:Statins
Sari la navigare
Sari la căutare
class of drugs used to lower cholesterol levels | |||||
Încarcă multimedia | |||||
Este un/o |
| ||||
---|---|---|---|---|---|
Subclasă a |
| ||||
Parte din |
| ||||
| |||||
Subcategorii
Această categorie conține doar următoarea subcategorie.
H
Fișiere media din categoria „Statins”
Următoarele 42 fișiere se află în această categorie, dintr-un total de 42.
-
Advlip.jpg 911x615; 51 KB
-
Algorithm for statin-associated myopathy.jpg 810x900; 88 KB
-
Biosynthesis-dielsalder.png 1.523x1.602; 77 KB
-
Biosynthesis-lovd.png 1.442x1.177; 60 KB
-
Cholesterolbiosynthesis.png 1.930x2.427; 40 KB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s2.ogv 20 s, 1.344 × 1.024; 15,49 MB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s3.ogv 20 s, 1.344 × 1.024; 12,31 MB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s4.ogv 20 s, 1.344 × 1.024; 10,26 MB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s5.ogv 19 s, 1.344 × 1.024; 18,75 MB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s6.ogv 13 s, 1.344 × 1.024; 10,5 MB
-
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s8.ogv 13 s, 1.344 × 1.024; 10,57 MB
-
Differential-epigenetic-reprogramming-in-response-to-specific-endocrine-therapies-promotes-ncomms10044-s9.ogv 13 s, 1.344 × 1.024; 8,86 MB
-
Estatina final.png 315x209; 13 KB
-
Estatina.png 578x174; 17 KB
-
Fluvastatina Grupo fluorofenil.jpg 468x311; 26 KB
-
HMG-CoA reductase pathway.svg 500x911; 16 KB
-
Metabolic pathway of a typical statin.png 4.762x4.757; 221 KB
-
Ogólny mechanizm plejotropowego działania statyn.png 3.507x2.480; 403 KB
-
Schematyczna budowa cząsteczki statyn.png 4.877x2.170; 109 KB
-
Statin final.svg 210x139; 14 KB
-
Statin mechanism v01.svg 652x282; 65 KB
-
Statin pharmacophore 2.png 3.787x2.861; 63 KB
-
Statin pharmacophore.png 665x614; 7 KB
-
Statin pharmacophore.svg 162x142; 10 KB
-
Statin Risks (6941350219).jpg 2.784x2.702; 1,08 MB
-
Statin-Test.png 838x759; 66 KB
-
Statin-use-cardiovascular-disease-death-rate.png 3.400x3.844; 1,4 MB
-
Statin-use-vs-share-of-population-with-high-blood-pressure.png 3.400x3.865; 1,37 MB
-
Statin.svg 385x116; 17 KB
-
Statinfamily.png 1.144x315; 48 KB
-
StatinPathway WP430.png 828x743; 62 KB
-
Statins-1.generation v01.svg 988x476; 103 KB
-
Statins77.png 516x461; 38 KB
-
Wpływ fluwastatyny na wskaźniki lipidowe 01.png 1.747x1.900; 69 KB
-
Wpływ fluwastatyny na wskaźniki lipidowe 02.png 1.747x1.891; 46 KB
-
Wpływ fluwastatyny na wskaźniki lipidowe 03.png 1.751x1.900; 78 KB
-
Wpływ prawastatyny na wskaźniki lipidowe 01.png 1.747x1.900; 75 KB
-
Wpływ prawastatyny na wskaźniki lipidowe 02.png 1.747x1.891; 77 KB
-
Wpływ prawastatyny na wskaźniki lipidowe 03.png 1.755x1.900; 82 KB